Dengfei Xu - Concepedia

Author

Dengfei Xu

Shanghai Jiao Tong University

Also Known As

DENGFEI XU, Deng-fei Xu, Dengfei Xu

Publications

184

Citations

H-Index

Concepts

All Affiliations

Shanghai Jiao Tong University Henan Provincial People's Hospital Zhengzhou University Shanghai Cancer Institute Renji Hospital

About

Dengfei Xu is an author at Shanghai Jiao Tong University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	66
2	Cell Biology	3	3	53
3	Immunology	3	3	53
4	Health Sciences	1	1	13
5	Pharmacology	1	1	13

Dengfei Xu

Publications

153

Citations

H-Index

Page 1

	Year	Citations
ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway Chunmei Yang, Hui Yuan, Jinyang Gu, Cell Death Discovery	2021	47
Cadherin 13 Inhibits Pancreatic Cancer Progression and Epithelial-mesenchymal Transition by Wnt/β-Catenin Signaling Dengfei Xu, Hui Yuan, Zihong Meng, Journal of Cancer	2020	23
Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages Zhilei Cui, Zhengshang Ruan, Meigui Li, International Immunopharmacology Cancer ImmunosurveillanceIntermittent HypoxiaPd-l1 ExpressionMedicineHypoxia (Medicine)	2023	21
Exposure to an enriched environment promotes the terminal maturation and proliferation of natural killer cells in mice Zihong Meng, Tingting Liu, Yanfang Song, Brain Behavior and Immunity Knockout MouseHost ResponseDevelopmental BiologyImmunologyCell Death	2018	20
The N-Myc-responsive lncRNA MILIP promotes DNA double-strand break repair through non-homologous end joining Pei Lin Wang, Teng Liu, Yuchen Feng, Proceedings of the National Academy of Sciences	2022	17
KIF14 mediates cabazitaxel-docetaxel cross-resistance in advanced prostate cancer by promoting AKT phosphorylation Lina Liu, Mengyuan Li, Junshuo Zhang, Archives of Biochemistry and Biophysics Cancer BiologyTumor BiologyDrug ResistanceGenitourinary CancerCabazitaxel-docetaxel Cross-resistance	2023	13
CD47 blockade enhances therapeutic efficacy of cisplatin against lung carcinoma in a murine model Zhilei Cui, Dengfei Xu, Fafu Zhang, Experimental Cell Research Lung CarcinomaMedicineMurine ModelImmunologyImmune Checkpoint Inhibitor	2021	12

Page 1